How Much Inositol Should You Take for OCD?

The dose used in the only controlled clinical trial of inositol for obsessive-compulsive disorder is 18 grams per day, taken orally as a powder. That figure comes from a small but often-cited double-blind crossover study in which 13 patients took either 18 g of inositol or placebo for six weeks at a time, and their OCD symptom scores dropped significantly during the inositol phase. The number sounds enormous compared to most supplements, and it raises practical questions about side effects, how to actually consume that much, and whether the evidence is strong enough to act on.

What the Clinical Trial Found

The landmark study was published in the American Journal of Psychiatry in 1996. Thirteen people with OCD completed a double-blind, controlled crossover trial comparing 18 g/day of inositol against placebo, with each phase lasting six weeks. The participants scored significantly lower on the Yale-Brown Obsessive Compulsive Scale (a standard measure of OCD severity) while taking inositol than while taking placebo.¹ A crossover design means each person served as their own control, taking both inositol and placebo at different times, which helps account for individual variability even with small sample sizes.

This is the study that virtually every discussion of inositol for OCD traces back to. A separate review of controlled inositol trials in psychiatry confirmed that the 18 g dose produced meaningful reductions in OCD symptoms compared to placebo and noted that inositol had also shown benefit in depression and panic disorder at the same dose.² That consistent use of 18 g across psychiatric conditions is not a coincidence; it reflects the amount researchers believed was needed to meaningfully raise inositol levels in the brain.

The obvious caveat: 13 people is a very small trial. It has never been replicated at scale for OCD specifically. Researchers have called for larger follow-up studies for over two decades, but they have not materialized. So the 18 g figure is the best available clinical data point, not a well-established treatment standard.

Why the Dose Is So High

Eighteen grams is far more than you would take of most supplements, and there is a physiological reason. Inositol has to cross the blood-brain barrier to affect brain signaling, and the transport system that moves it across is low-capacity and easily saturated. Research measuring myo-inositol transfer through cerebral capillaries in animals found that the transport mechanism reaches half its maximum capacity at very low concentrations and relies on a combination of simple diffusion and a specialized carrier that is picky about molecular shape.³ In plain terms, the brain does not let much inositol in at a time. To push enough across, you need a large amount circulating in the blood, which means a large oral dose.

This bottleneck also explains why lower doses used in some consumer supplements, typically 500 mg to 2 g, have not been studied for OCD. There is no clinical evidence that those amounts raise brain inositol levels enough to affect obsessive-compulsive symptoms. The gap between what is available on store shelves and what was used in the trial is enormous, and it matters.

How Inositol May Affect OCD Symptoms

Inositol is a naturally occurring sugar alcohol that the body uses as a building block for a signaling system inside brain cells. When serotonin and certain other neurotransmitters bind to their receptors, the downstream signal inside the cell depends partly on a molecule called phosphatidylinositol, which is built from inositol. The theory is that supplementing with extra inositol replenishes the raw material for this signaling cascade, potentially restoring receptor sensitivity that has become blunted.

Laboratory work on rat brain cells showed that adding myo-inositol reversed a process in which serotonin receptors become less responsive after repeated stimulation. The researchers found that myo-inositol potentiated serotonin’s effects and eliminated the desensitization that normally occurs, suggesting that the desensitization was partly caused by depletion of the inositol-based signaling substrate in the first place.⁴ Since the most effective medications for OCD are drugs that increase serotonin activity, a supplement that helps serotonin receptors stay responsive would, at least in theory, work through a complementary pathway.

The review of controlled inositol trials explicitly connected these dots, noting that because serotonin reuptake inhibitors benefit OCD and inositol has been reported to reverse serotonin receptor desensitization, the molecule was a logical candidate for clinical testing.² It is an elegant rationale, though the gap between a lab demonstration on rat neurons and reliable symptom relief in human OCD patients remains wide.

Brain Inositol Levels in People with OCD

One piece of indirect support comes from brain imaging. A magnetic resonance spectroscopy study comparing unmedicated OCD patients with healthy controls found that the OCD group had higher levels of myo-inositol in the medial thalamus before treatment. The study also found that myo-inositol concentrations in the caudate nucleus correlated with disease severity on the Yale-Brown Obsessive Compulsive Scale.⁵

This is worth thinking about carefully, because it does not tell a simple story. If people with OCD already have elevated inositol in certain brain regions, you might expect that adding more would make things worse, not better. But brain chemistry is not a bathtub where more is always more. The relationship between regional concentrations of a signaling molecule and the functional sensitivity of the receptors that depend on it is not straightforward. Elevated regional myo-inositol could reflect a compensatory response to dysfunctional signaling rather than an excess that is causing problems. The imaging data confirms that inositol metabolism is altered in OCD, but it does not resolve whether supplementation helps by fixing a bottleneck, bypassing a broken pathway, or doing something else entirely.

Side Effects and Tolerability

The good news for anyone considering a high-dose inositol regimen is that the substance appears to be well tolerated. A review of clinical safety evidence found that only the highest dose tested, 12 g per day, produced mild gastrointestinal side effects such as nausea, gas, and diarrhea. Importantly, the severity of those side effects did not increase as the dose went up further.⁶ That means the jump from 12 g to 18 g does not appear to bring proportionally worse gut problems, though some people will be more sensitive than others.

In the OCD trial itself, inositol at 18 g/day did not cause serious adverse events. Side effects when they did occur were mild and mostly digestive. This profile is considerably gentler than the side effects commonly associated with SSRIs at OCD-level doses, which often include sexual dysfunction, weight changes, and emotional blunting. For people who have struggled with SSRI tolerability, the side-effect profile is a significant part of inositol’s appeal.

A practical approach many users take is to start with a lower amount, around 2 to 6 g per day, and gradually increase over a week or two toward the 18 g target. This allows the gut to adjust and makes it easier to identify if the supplement is causing any problems. Splitting the dose into two or three servings spread across the day can also reduce digestive discomfort.

Practical Challenges of Taking 18 Grams Daily

Eighteen grams of powder is roughly three to four heaping teaspoons. It dissolves reasonably well in water or juice and has a mildly sweet taste, since inositol is chemically related to glucose. Most people who take inositol at this dose use bulk powder rather than capsules, because you would need to swallow somewhere around 18 to 36 capsules a day to reach the target dose depending on capsule size. That alone makes capsule form impractical for most people.

Cost can add up. A month’s supply of pharmaceutical-grade myo-inositol powder at 18 g/day typically runs between $20 and $50 depending on the brand and source, which is comparable to or less than many prescription copays. But it requires buying from a supplement retailer, and the supplement market is unregulated compared to pharmaceuticals. Quality can vary between manufacturers. Looking for products that carry third-party testing certifications is a reasonable precaution.

Adherence is its own challenge. Mixing a powder into liquid two or three times a day, every day, for at least six weeks is more effortful than popping a pill. The OCD trial ran for six weeks per phase, and there is no clinical data on what happens with shorter or longer courses. Nobody knows the optimal duration, whether benefits persist after stopping, or whether ongoing daily use is necessary to maintain any improvement. These are genuine unknowns, not questions with hidden answers.

Inositol for Panic Disorder and Depression

The same 18 g dose has been tested across several psychiatric conditions beyond OCD. In controlled trials, inositol outperformed placebo for both panic disorder and depression. A crossover trial directly comparing 18 g of myo-inositol against fluvoxamine (a commonly prescribed SSRI) for panic disorder found that inositol was at least comparable to the drug.⁷ The researchers noted that continuing reports of efficacy across depression, panic, and OCD should prompt larger replication studies, though those studies largely have not been conducted.

This cross-disorder pattern is relevant for OCD because many people with OCD also experience panic attacks or depression. If inositol offers modest benefits across several of these conditions simultaneously, its practical value could be greater than what a single-condition trial captures. On the other hand, the small sample sizes across all these trials mean the overall evidence base is thin by modern standards. No large pharmaceutical company has a financial incentive to fund expensive trials of a natural compound that cannot be patented, and that economic reality largely explains why the research stalled after the 1990s.

What Inositol Is Not

It is worth being clear about what the evidence does and does not support. Inositol at 18 g/day showed a statistically significant improvement in OCD symptoms in one small trial. That is not the same as saying it is an effective treatment for OCD in the way that SSRIs at therapeutic doses or exposure and response prevention therapy are effective treatments. Those interventions are backed by dozens of randomized controlled trials, large sample sizes, and decades of clinical experience. Inositol has one 13-person crossover study.

The practical position most psychiatrists would take is that inositol is an interesting supplement with a plausible mechanism and preliminary positive data, not a first-line treatment. It might be worth trying as an add-on if standard treatments are not working well enough or are not tolerable, but it should not replace established therapies. Anyone with moderate to severe OCD who tries inositol instead of evidence-based treatment is making a high-stakes gamble on very limited data.

There is also no evidence about combining inositol with SSRIs specifically for OCD. Some researchers have examined inositol combined with serotonin reuptake inhibitors for depression, but whether the combination is helpful, neutral, or counterproductive for OCD remains untested. If you are already on medication for OCD and considering adding inositol, discussing it with your prescriber is not just polite advice; it is genuinely important because both substances affect serotonin-related signaling, and unexpected interactions are possible even if inositol is generally safe on its own.

The Myo-Inositol vs. D-Chiro-Inositol Distinction

If you start shopping for inositol supplements, you will encounter different forms. The two most commonly sold are myo-inositol and D-chiro-inositol. All the psychiatric research, including the OCD trial, used myo-inositol. D-chiro-inositol is primarily studied in the context of insulin signaling and polycystic ovary syndrome, not brain chemistry. The blood-brain barrier transport research confirmed that the carrier system is stereospecific: it recognizes myo-inositol and the related form scyllo-inositol, but not chiro-inositol.³ In other words, D-chiro-inositol may not even get into the brain efficiently. If you are taking inositol with the goal of affecting OCD symptoms, myo-inositol is the only form with relevant evidence behind it.

Some products marketed for hormonal health blend both forms in a 40:1 ratio of myo-inositol to D-chiro-inositol. These are designed for metabolic conditions, not psychiatric ones, and the total myo-inositol dose in a typical serving is usually around 2 to 4 g, far below the 18 g studied for OCD. Buying a product with the right label but the wrong dose is one of the easiest mistakes to make.

How Long Before You Would Know If It Is Working

The OCD trial assessed symptoms after six weeks on each treatment.¹ That is the only time point with published data, so there is no way to say whether benefits appear sooner. SSRIs for OCD typically take four to eight weeks to produce noticeable improvement, and they are sometimes trialed for up to 12 weeks before being deemed ineffective. A similar or longer timeline for inositol is plausible given that it appears to work through related serotonin pathways, but this is speculation rather than established fact.

If you decide to try inositol for OCD, committing to at least six full weeks at the 18 g dose before evaluating whether it is helping is a reasonable minimum based on the trial’s design. Stopping after two weeks and concluding it does not work would be premature by any standard. Tracking your symptoms with a simple daily rating, even just a 1-to-10 scale of how much your obsessions and compulsions interfered with your day, gives you something concrete to compare over time rather than relying on the unreliable feeling that things are “about the same.”